Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
PUT
General Dynamics
GD
$106B
| $55.4M | 0.03% |
272,400
+103,800
| +62% | +$21.2M |
|
552
Western Alliance Bancorporation
WAL
$8.92B
| $55.3M | 0.03% |
977,297
-533,752
| -35% | -$29.7M |
|
553
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $55.2M | 0.03% |
1,172,300
-960,700
| -45% | -$44.5M |
|
554
CALL
Kraft Heinz
KHC
$30.1B
| $55.2M | 0.03% |
710,100
+468,500
| +194% | +$36.8M |
|
555
PUT
AB InBev
BUD
$158B
| $54.7M | 0.03% |
490,600
+218,500
| +80% | +$25.7M |
|
|
OIL
556
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
| $54.3M | 0.03% |
8,308,619
+5,388,199
| +185% | +$31.6M |
|
557
Bio-Techne
TECH
$11.2B
| $54M | 0.03% |
1,666,944
+372,700
| +29% | +$11.8M |
|
558
CALL
UnitedHealth
UNH
$358B
| $53.9M | 0.03% |
244,700
+5,800
| +2% | +$1.23M |
|
|
AABA
559
CALL
DELISTED
Altaba Inc
AABA
| $53.9M | 0.03% |
771,800
-126,900
| -14% | -$8.83M |
|
560
RLJ Lodging Trust
RLJ
$1.67B
| $53.7M | 0.03% |
2,443,093
-562,958
| -19% | -$12.2M |
|
561
CALL
United States Oil Fund
USO
$1.77B
| $53.6M | 0.03% |
557,438
+167,713
| +43% | +$14.9M |
|
562
CALL
MGM Resorts International
MGM
$11.1B
| $53.4M | 0.03% |
1,600,700
+634,600
| +66% | +$20.4M |
|
563
CMS Energy
CMS
$22.1B
| $53.3M | 0.03% |
1,126,843
+1,076,806
| +2,152% | +$52.2M |
|
564
PUT
W.W. Grainger
GWW
$62.2B
| $53.2M | 0.03% |
225,000
+128,800
| +134% | +$26.6M |
|
565
PUT
Northrop Grumman
NOC
$81.6B
| $53M | 0.03% |
172,600
+51,800
| +43% | +$15.6M |
|
566
WEX
WEX
$6.78B
| $52.9M | 0.03% |
374,821
-750,016
| -67% | -$93.9M |
|
|
FOLD
567
DELISTED
Amicus Therapeutics
FOLD
| $52.8M | 0.03% |
3,670,668
+1,794,110
| +96% | +$24.6M |
|
568
PUT
Delta Air Lines
DAL
$60B
| $52.7M | 0.03% |
941,700
-232,200
| -20% | -$12.1M |
|
569
Camden Property Trust
CPT
$11.1B
| $52.6M | 0.03% |
571,712
+209,087
| +58% | +$19.3M |
|
570
Pegasystems
PEGA
$5.51B
| $52.5M | 0.03% |
2,228,434
+619,002
| +38% | +$16.6M |
|
571
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $52.4M | 0.03% |
616,900
+27,500
| +5% | +$2.3M |
|
|
CNH
572
CNH Industrial
CNH
$16.7B
| $52.1M | 0.03% |
4,471,515
+4,362,694
| +4,009% | +$48.2M |
|
573
CALL
Biogen
BIIB
$31.1B
| $51.9M | 0.03% |
162,900
-95,900
| -37% | -$30.8M |
|
574
Commault Systems
CVLT
$6.26B
| $51.6M | 0.03% |
982,536
+366,251
| +59% | +$20.3M |
|
575
Cencora
COR
$59.2B
| $51.4M | 0.03% |
559,345
-524,533
| -48% | -$43.4M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.